Results 181 to 190 of about 222,862 (245)

Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATP. [PDF]

Cancer Biol Ther
Manouchehri JM, Datta J, Marcho LM, Stover D, Ganju RK, Ramaswamy B, Carson WE, Mittra A, Zhang X, Schnell PM, Yue Y, Rubinstein MP, Cherian MA.   +12 more
europepmc   +1 more source

Comparative Survival Analysis of Anti‐Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR‐TKI Treatment: A Retrospective Cohort Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Advanced‐stage EGFR‐mutated lung non‐small cell lung cancer (NSCLC) challenges current treatment paradigms, particularly after frontline EGFR‐TKI therapy failure. This study investigates the survival impact of combined anti‐angiogenic agent and immunochemotherapy (AICT) for this population.
Yi‐Tse Su, Shu‐Farn Tey, Chung‐Ta Lee, Chien‐Yu Lin, Jeng‐Shiuan Tsai, Chien‐Chung Lin, Chin‐Wei Kuo   +6 more
wiley   +1 more source

Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS). [PDF]

BMC Res Notes
Boehmerle W, Hagenacker T, Leo M, Schmitt LI, Lehmann HC, Klein I, Stegherr R, Konietschke F, Endres M, Huehnchen P.   +9 more
europepmc   +1 more source

A Preliminary Study on the Therapeutic Role of γδT Cells in Triple‐Negative Breast Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study was aimed to elucidate the cytotoxic effects of γδT cells on triple‐negative breast cancer (TNBC) cells and assess their antitumor efficacy in a mouse xenograft model. Furthermore, the underlying mechanisms of γδT cell action on TNBC were explored.
Shi Qiu, Qin‐Yu Han, Xian Zhao, Wen‐Jing Li, Xiang‐Qi Li   +4 more
wiley   +1 more source

Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible? [PDF]

World J Gastroenterol
Chen JQ, Lan X.
europepmc   +1 more source

Association of ABC Efflux Transporter Genetic Variants and Adverse Drug Reactions and Survival in Patients with Non-Small Lung Cancer. [PDF]

Genes (Basel)
Seguin CS, Fidelis GFS, Dagli-Hernandez C, Vasconcelos PENS, Morau MV, Matos YG, Perroud MW, de Carvalho Pincinato E, Moriel P.   +8 more
europepmc   +1 more source

Self‐Assembly of Noncanonical Peptides: A New Frontier in Cancer Therapeutics and Beyond

Macromolecular Bioscience, EarlyView.
Representative examples of noncanonical peptide assemblies in anticancer therapeutics, biomaterials, regenerative medicine, molecular imaging, and catalysis are discussed, highlighting enzyme‐instructed self‐assembly as a valuable approach for constructing biomimetic and bioinspired materials that bridge the interface between biological systems and ...
Lin Bai, Meihui Yi, Bing Xu
wiley   +1 more source

Efficacy and mechanisms of Angelica sinensis in treating endometrial cancer: an integrated study. [PDF]

Discov Oncol
Li Z, Jia C, Zhou Y, Wang Q.
europepmc   +1 more source

Innovative Thermosensitive Composite Materials: Merging Poloxamer PF‐127 and Polysaccharides for Enhanced Functional Properties

Macromolecular Materials and Engineering, EarlyView.
The poloxamer Pluronic‐F‐127‐based hydrogels are improved by the implementation of polysaccharides with different concentration ranges and structural organizations. The interactions between the polysaccharide structures and the poloxamer micellar aggregation confer the system better rheological properties and longer drug release times explained by ...
Marcos Blanco‐López, Inmaculada de Dios‐Pérez, Álvaro González‐Garcinuño, Antonio Tabernero, Eva Martín del Valle   +4 more
wiley   +1 more source

The Role of Nanoparticles in Therapy of Real-World Patients with Pancreatic Cancer: A Scoping Review. [PDF]

Cancers (Basel)
Konstantinidis I, Tsokkou S, Katsikeros D, Chatzikomnitsa P, Papakonstantinou M, Liampou E, Toutziari E, Giakoustidis D, Bageas P, Papadopoulos V, Giakoustidis A, Papamitsou T.   +11 more
europepmc   +1 more source